Showing 1361-1370 of 3287 results for "".
Seeing the Spectrum: Recognizing Lichen Planus in Various Skin Types
https://practicaldermatology.com/youngmd-connect/resident-resource-center/seeing-the-spectrum-recognizing-lichen-planus-in-various-skin-types/23393/How Lichen Planus presents in various skin types and tips on differential diagnosis.Assessing the Pediatric Dermatology Workforce
https://practicaldermatology.com/topics/pediatric/assessing-the-pediatric-dermatology-workforce/23834/Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/22078/Dermatologists Give AI A Thumbs Up
https://practicaldermatology.com/topics/practice-management/dermatologists-give-ai-a-thumbs-up/23673/Dr. Vishal Patel talks augmented intelligence and how it may change practice.One-and-Done Tattoo Removal: Is It Possible With Q-switched Technology?
https://practicaldermatology.com/topics/practice-management/one-and-done-tattoo-removal-is-it-possible-with-q-switched-technology/21019/Newer and more powerful nanosecond lasers coupled with improved techniques have greatly improved the ability to clear tattoos faster and treat resistant colors.New Tech Marries Data with Dermatology
https://practicaldermatology.com/topics/practice-management/new-tech-marries-data-with-dermatology/23574/Mindera Health seeks to cut costs and improve outcomes in psoriasis care.Acne Treatment Advances
https://practicaldermatology.com/topics/acne-rosacea/acne-treatment-advances/23506/Boosting adherence and results with energy-based devices.Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Should You Restrict a Procedure?
https://practicaldermatology.com/series/editors-message/should-you-restrict-a-procedure/23931/Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.